Exploring GLP-1, GIP, and Glucagon Receptor Agonism in Obesity and Neurodegeneration | Retatrutide News

The review highlights GLP-1, GIP, and glucagon receptor agonism's potential in treating obesity and neurodegeneration. It suggests further research is n...
Clinical Trials · October 22, 2026